Implantable syncope monitor and method of using the same

• US 6,719,701 B2
• Filed: 01/28/2002
• Issued: 04/13/2004
• Est. Priority Date: 01/28/2002
• Status: Active Grant

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Inventors: Lade, Kipton P.
• Primary Examiner(s): Hindenburg, Max F.
• Assistant Examiner(s): Natnithithadha, Navin
• Application Number:
  US10/059,678
• Publication Number:
  US 20030144595A1
• Time in Patent Office: 806 Days
• Field of Search: 600/485, 600/486, 600/483, 600/500, 600/508, 600/509, 600/515, 600/300, 600/301, 607/1, 607/2, 607/9, 607/17, 607/18, 607/23
• US Class Current: 600/485
• CPC Class Codes: A61N 1/3622 comprising two or more electrodes co-operating with different heart regions
• CPC Class Codes: A61N 1/36514 controlled by a physiological quantity other than heart potential, e.g. blood pressure controlled by two or more physical parameters A61N1/36585
• CPC Class Codes: A61N 1/36535 controlled by body position or posture

Abstract

An implantable monitor and method to acquire, store, and display physiological data for the diagnosis of vasovagal syncope or intermittent cardiac arrhythmias. Physiological data monitored preferably comprises heart rate, blood pressure, and body posture. Physiological signals are monitored until detection of an event that triggers the storage of data. A storage-triggering event may be a maximum or minimum heart rate or blood pressure, a dramatic change in heart rate or blood pressure, or a patient-activated signal. In one embodiment, confirmed detection of vasovagal syncope by the monitor causes a telemetric command to enable a syncope therapy. Storage of physiologic data is triggered by predetermined arrhythmia or syncope detection criteria and appropriate stimulation therapy for the detected condition may be enabled.

Claims

1. A method of monitoring physiological signals comprising:

acquiring at least a first and a second physiological signals;

if the first physiological signal represents a blood pressure trigger event, determining a direction of change of the trigger event;

if the direction of change of the trigger event represents a decrease in blood pressure, analyzing the second physiological signal to determine if a heart rate has changed since the decrease in blood pressure; and

confirming a likelihood of vasovagal syncope if the heart rate does not increase.

2. The method of claim 1, further comprising, upon detection of the blood pressure trigger event, storing acquired physiological signals for a predetermined period.

3. The method of claim 2, further comprising displaying stored physiological data.

4. The method of claim 1, wherein acquiring the second physiological signal comprises acquiring an electrocardiogram (ECG) signal.

5. The method of claim 4, wherein acquiring the second physiological signal comprises acquiring heart rate measurement.

6. The method of claim 1, further comprising acquiring body posture measurement.

7. The method of claim 5, wherein acquiring heart rate measurement comprises detecting a maximum heart rate.

8. The method of claim 5, wherein acquiring heart rate measurement comprises detecting a minimum heart rate.

9. The method of claim 5, wherein acquiring heart rate measurement comprises detecting a predetermined change in the heart rate.

10. The method of claim 1, wherein analyzing the first physiological signal comprises detecting a maximum blood pressure.

11. The method of claim 1, wherein analyzing the first physiological signal comprises detecting a minimum blood pressure.

12. The method of claim 1, wherein analyzing the first physiological signal comprises detecting a predetermined change in blood pressure.

13. The method of claim 3, further comprising treating vasovagal syncope if vasovagal syncope is confirmed.

14. The method according to claim 13, wherein treating vasovagal syncope comprises delivering cardiac stimulation pulses at a rate above an intrinsic heart rate.

15. The method of claim 1, wherein selectively confirming vasovagal syncope comprises diagnosing intermittent cardiac arrhythmia.

16. The method according to claim 15, wherein confirming intermittent cardiac arrhythmia comprises confirming bradycardia.

17. The method according to claim 16, wherein confirming intermittent cardiac arrhythmia comprises confirming any one of low rate tachycardia, high rate tachycardia, and fibrillation.

18. The method of claim 16 further comprising treating the intermittent cardiac arrhythmia.

19. A device for monitoring physiological signals comprising:

a plurality of sensors that acquire first and second physiological signals;

a detector connected to at least one of the sensors, wherein the detector is operative to detect if the first physiological signal represents a blood pressure trigger event, and to determine a direction of change of the trigger event;

a control circuit that analyzes the second physiological signal to determine if a heart rate has changed if the direction of change of the trigger event represents a decrease in blood pressure, wherein the circuit determines a potential vasovagal syncope condition exists if the heart rate has not increased.

20. The device of claim 19, wherein the second physiological signal comprises an electrocardiogram (ECG) signal.

21. The device of claim 20, wherein the second physiological signal comprises a heart rate measurement.

22. The device of claim 19, wherein the second physiological signal comprises a body posture measurement.

23. The device of claim 21, wherein the heart rate measurement comprises any one of:

a maximum heart rate;

a minimum heart rate; and

a predetermined change in the heart rate.

24. The device of claim 19, wherein the control circuit analyzes the first physiological signal by analyzing any one of:

a maximum blood pressure;

a minimum blood pressure; and

a predetermined change in blood pressure.

25. A cardiac stimulation device capable of monitoring physiological signals, the device comprising:

means for detecting a blood pressure decrease;

means for determining if a heart rate changes subsequent to the detected blood pressure decrease; and

means for determining that a potential vasovagal syncope condition exists if the heart rate does not increase.

26. The device of claim 25, wherein the second physiological signal comprises an electrocardiogram (ECG) signal.

27. The device of claim 26, wherein the second physiological signal comprises a heart rate measurement.

28. The device of claim 25, wherein the second physiological signal comprises a maximum heart rate.

29. The device of claim 27, wherein the heart rate measurement comprises any one of:

a maximum heart rate;

a minimum heart rate; and

a predetermined change in the heart rate.

30. The device of claim 25, wherein the control circuit analyzes the first physiological signal by analyzing any one of:

a maximum blood pressure;

a minimum blood pressure; and

a predetermined change in blood pressure.